Issued Patents 2020
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10799584 | Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents | Xiaoyan Zhang, Dimiter S. Dimitrov, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2020-10-13 |
| 10758526 | Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways | Xiaoyan Zhang, Dimiter S. Dimitrov, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2020-09-01 |
| 10758614 | Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase | Xiaoyan Zhang, Dimiter S. Dimitrov, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2020-09-01 |
| 10758613 | Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells | Xiaoyan Zhang, Dimiter S. Dimitrov, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2020-09-01 |
| 10716782 | LPT-723 and immune checkpoint inhibitor combinations and methods of treatment | Linping Zhang, Xiaoyan Zhang | 2020-07-21 |
| 10668055 | Cancer treatment using combinations of ERK and RAF inhibitors | Dean Welsch, Gary A. DeCrescenzo, Jeffrey James Roix | 2020-06-02 |
| 10617723 | C. novyi for the treatment of solid tumors in humans | Shibin Zhou, Bert Vogelstein, Kenneth W. Kinzler | 2020-04-14 |
| 10604582 | Anti-CD276 antibodies (B7H3) | Dimiter S. Dimitrov, Zhongyu Zhu, Bradley St. Croix, Steven Seaman, Xiaoyan Zhang +2 more | 2020-03-31 |
| 10604583 | Anti-CD276 polypeptides, proteins, and chimeric antigen receptors | Rimas J. Orentas, Zhongyu Zhu, Crystal L. Mackall, Dimiter S. Dimitrov, Bradley St. Croix | 2020-03-31 |